Levobupivacaine

Active ingredient description

Levobupivacaine is a long acting local anaesthetic and analgesic. It blocks nerve conduction in sensory and motor nerves largely by interacting with voltage sensitive sodium channels on the cell membrane, but also potassium and calcium channels are blocked. In addition, levobupivacaine interferes with impulse transmission and conduction in other tissues where effects on the cardiovascular and central nervous systems are most important for the occurrence of clinical adverse reactions.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Levobupivacaine
N Nervous system → N01 Anesthetics → N01B Anesthetics, local → N01BB Amides
Discover more medicines within N01BB10

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
UK

Medicines

Levobupivacaine is the active ingredient of these drugs:

Drug
Countries

Finland France Hong Kong Ireland Lithuania

Spain

Levobupivacaine is also found within below combination drugs:

NOVABUPI

Structural formula

Graphic representation of the active ingredient's molecular structure

Chemical formula: C₁₈H₂₈N₂O
Molecular mass: 288.428 g/mol

External identifiers

CAS Substance: 27262-47-1
DrugBank Drug: DB01002
KEGG Drug: D08116
PubChem Compound: 92253
RxNorm Ingredient: 259453
SNOMED-CT Concept: 334207003
Levobupivacaine (substance)
SNOMED-CT Concept: 387011006
Levobupivacaine (substance)
UNII Identifier: A5H73K9U3W
LEVOBUPIVACAINE
UNII Identifier: J998RDZ51I
LEVOBUPIVACAINE HYDROCHLORIDE